Your Messages Inbox
Your Article Summary
See Latest ArticlesProton Pump Inhibitor omeprazole available soon without prescription: New therapeutic option for heartburn
BayNews International, 08/17/09
Bayer Consumer Care New Zealand will launch the OTC Proton Pump Inhibitor omeprazole in New Zealand under the Losec brand in September. This follows the Medicine Classification Committee's recommended approval for the Rx to OTC switch of omeprazole 10 mg, which became effective by Gazette notice on March 2009. Bayer New Zealand received an OTC license for omeprazole from AstraZeneca for the marketing of OTC omeprazole.
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09
FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Gen-Probe, 10/30/09
Gyrus PlasmaKinetic bipolar coagulation device for liver resection
Australian and New Zealand Journal of Surgery, 11/13/09
Today in Physician/Patient Trends...keeping you current
Receive free subspecialty "5-minute updates" via email
Predicting age at onset of menopause: Testing the "adaptive onset" hypothesis
Maturitas, 11/11/09
Urinary Diversion Trends at a High Volume, Single American Tertiary Care Center
The Journal of Urology, 11/02/09
Trends in prescribing and self-poisoning in relation to UK regulatory authority warnings against use of SSRI antidepressants in under-18-year-olds
British Journal of Clinical Pharmacology, 11/02/09
Article Search
Sponsor